Deep sternal wound infection (DSWI) is a serious complication of cardiac surgery with high additional morbidity and mortality. The incidence is less than 1%, but associated with mortality rates between 14 and 47% [1] . There are multiple predisposing factors ranging from patient-risk factors (i.e. obesity, chronic obstructive pulmonary disease, advanced age, male sex), perioperative patient management (i.e. antibiotic prophylaxis, hair removal, blood transfusion, ventilation time) and the surgical procedure
APPENDIX. CONFERENCE DISCUSSION
Dr T. Elenbaas (Eindhoven, Netherlands): Your paper tries to answer a very important question. You only have 2% deep sternal wound infections, which I think is very good, and even better is your outcome after treatment, the overall mortality being only 3.1%. Now, back to the topic of this presentation. Although I agree with the conclusion, I was wondering why you combined those two groups. As you mentioned yourself, a limitation of the study is that there is a selection bias based on the decision of the surgeon to go for direct closure or secondary closure after VAC therapy.
I think that these groups are not quite comparable, although the patient characteristics, as you presented them, show more or less the same data. I think if a patient is deep septic and the sternum is fractured in several places, and he is haemodynamically unstable, he would probably be better off if treatment were focused on his septicaemia and good wound drainage rather than on direct reclosure.
First question, how is the decision made in your centre between these two treatment modalities? The second question is about the timing of wound closure. You stated that VAC therapy could be shorter. In your references, you mentioned a paper from the Lund group, by Sjögren, where the C-reactive protein level is one of the guiding factors for timing of sternal closure. My question is, what is the value of the CRP level in your clinic in the treatment of mediastinitis or the timing of reclosure?
And the last question concerns the readmission rate which was the same in both groups, 5%. And the question is, what did you do when the patients were readmitted? Was it just a week of additional antibiotic therapy or did you have to drain the substernal space again? And how were these two additional therapies divided between the two groups?
Dr Rodriguez: In regard to the first question, why use direct closure or vacuum-assisted therapy, that's one of the limitations of this study. The VAT therapy started in our clinic around 2001-02. So we knew that most of the direct closure patients in this series were before 2001. Patients who came with an infected wound were opened and then closed immediately afterwards. As mentioned previously, that was between the time frame of 1999 and late 2001/2002. At this moment in our clinic we are performing mainly VAT therapy. That's also why the patient numbers are quite different, 105 VAT therapy and 54 from the direct closure group. So there was nothing behind the decision, it was just the time frame in which surgery was performed.
We did not analyse the CRP levels with our patients. We were just analysing the microbiology. This is the answer to your second question. And the third question, could you repeat it?
Dr Elenbaas: What did you have to do on readmission? Dr Rodriguez: All the patients that were readmitted came with the diagnosis of sternal wound infection. So all the patients that were analysed in this paper were directly taken to the OR and were opened. Debridement was performed and either direct closure or VAT therapy was performed.
Dr T. Gudbjartsson (Reykjavik, Iceland): I was wondering what was the length of the follow-up? And do you have any information on chronic fistulas in the groups? And my other question is about the cultures: how were they performed, how were they verified, was it a tissue sample or was it just a swab?
Dr Rodriguez: It was a swab probe. This is why I said we are changing right now to biopsies to see if that has an influence. And in regard to your first question, could you repeat it, sir.
Dr Gudbjartsson: Did you analyse the late or the chronic fistulas, are they included in the number of patients readmitted?
Dr Rodriguez: I cannot bring to mind the number of current fistulas we had, but the fistulas were treated as deep sternal wound infections so we included all these patients. Because this is a retrospective study, we don't have a very long-term follow-up. Patients from 1999 or 2002 are perhaps already dead, so we did not make a complete follow-up.
Dr Gudbjartsson: Because it could be that you had positive cultures and you closed the patients, and they can turn up many months or years later with a reinfection.
Dr Rodriguez: We do know that some patients with positive cultures had a readmission rate. However, we did not analyse further. We agree that it would be important. itself. The most important aspect in the treatment of DSWI is to prevent it. Basic surgical rules, like sterility during the procedure, should be taken for granted. A further prophylactic treatment has recently been described by Schimmer et al. [2] . They reported a significant reduction of sternal wound complications after gentamicin-collagen sponge application before chest closure in a controlled, prospectively randomized, double-blind study.
If DSWI is present, the patients should be treated immediately. A specific group in the hospital with expertise in the treatment of wound complications, composed of surgeons (cardiac, thoracic and/or plastic), specially trained nurses and infectious disease specialists should follow and treat these patients. It is advisable that a systematic classification of the wound complication should be performed. This is important, not only for scientific reasons to compare clinical outcomes, but also to treat different forms of wound infections with a specific algorithm. One systematic classification of postoperative mediastinitis was introduced by El Oakley and Wright [1] in 1996. Different groups have further developed a management algorithm for DSWI [3, 4] . Individual algorithms based on local and institutional experience may be applied.
In an article by Biefer et al. [5] published in this issue, a single centre experience of 159 out of 7746 patients with DSWI following cardiac surgery is presented. Patients were treated either with vacuum-assisted-therapy (VAT) or with direct wound closure, and analysed, taking into account the results of cultures taken at the time of closure.
In 75% of patients, microbiological results were positive at the time of wound closure. There was no significant difference with regard to re-admission for reinfection in both groups. However, patients undergoing VAT stayed for a significantly longer period of time in the hospital.
The authors conclude that negative microbiological results are not mandatory before wound closure in patients with DSWI. They also state that the duration of VAT may therefore be shortened.
The basic principles in the treatment of DSWI are removal of foreign materials, wound debridement and broad-spectrum antibiotic therapy. The goal is to reduce or minimize bacterial load of the infected area, before further steps can be performed. These steps are either primary refixation of the sternum or reconstructive surgery of the chest with various plastic surgery techniques. Variation of one or the other technique may be applied with regard to the initial presentation.
Application of VAT has been introduced as an additional standard therapy in DSWI, because it induced several local effects which have been addressed in the article by Biefer et al.
Whether negative microbiological results are mandatory before the wound can be closed in DSWI remains controversial. Negative microbiological samples taken from the wound do not mean that the wound is completely free of any infection and therefore wound closure is often performed with negative culture results, although bacteria are still present. On the other hand, microbiological results taken from optimal culturing methods as described by Tammelin et al. [6] can improve bacteriological diagnosis, and thereby surgical outcome.
As patients with DSWI are often critically ill, the success of wound treatment may also depend on their immune function. In other words, although we use optimal antibiotic treatment to sterilize the wound, the outcome of the DSWI may still be disastrous in patients with immune deficiency. Conversely, treatment of DSWI with adequate antibiotic treatment and early surgical wound closure can be successful in a patient with normal immunity, although microbiological results of the wound are still positive.
In summary, DSWI as a serious postoperative complication should be treated with priority and by a special team following a specific classification and treatment algorithm. Identification of patients at risk and prophylaxis to prevent wound complications is essential.
